We want to build a strong regional position – DNA ERA responds to questions from potential investors

Still wavering on whether to indicate your interest in the DNA ERA opportunity? We have information that could help with your decision. Read the DNA ERA and Crowdberry team's answers to actual questions from other investors. At the moment, our platform is less than 25% short of the target amount, so don't wait too long.

Learn in the article…

• Why DNA ERA focuses on the CEE region.
• What the company's marketing strategy is and why awareness about DNA is important.
• Which partners would be of interest to DNA ERA in the event of an exit.

How many ‘features’ can you analyse now and how many will you be able identify in 5 years?

Jakub Šiška, DNA ERA (JŠ): By "feature", we mean individual results, e.g., vitamin D level is one "feature". We will be adding dozens of new features over the coming months. We can't keep adding new results indefinitely because research is ongoing. So new features will continue to be added for a long time.

Michaela Šišková, DNA ERA (MŠ): We can track 650,000 points within DNA. We are currently analysing several thousand of them, so in the next 5 years, we will still have plenty of new features to offer.

What is the capacity of tests and how quickly will my results come?

JŠ: There is no capacity problem in terms of the algorithm. From a lab perspective, the capacity is tens of thousands of tests per week, and we're not hitting that number yet. Results usually come in 3-4 weeks; we guarantee 5 weeks.